143 related articles for article (PubMed ID: 31957240)
1. Comprehensive analysis of mRNA-level and miRNA-level subpathway activities for identifying robust ovarian cancer prognostic signatures.
Tian S; Mi W; Zhang M; Xing L; Zhang C
J Cell Mol Med; 2020 Feb; 24(4):2582-2592. PubMed ID: 31957240
[TBL] [Abstract][Full Text] [Related]
2. Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.
Tian S; Tian J; Chen X; Li L; Liu Y; Wang Y; Sun Y; Zhang C; Lou G
Cell Physiol Biochem; 2017; 44(4):1325-1336. PubMed ID: 29183027
[TBL] [Abstract][Full Text] [Related]
3. Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Chang H; Gao Q; Ding W; Qing X
PLoS One; 2018; 13(3):e0194245. PubMed ID: 29570744
[TBL] [Abstract][Full Text] [Related]
4. sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
Zhang CL; Xu YJ; Yang HX; Xu YQ; Shang DS; Wu T; Zhang YP; Li X
Sci Rep; 2017 Nov; 7(1):15322. PubMed ID: 29127397
[TBL] [Abstract][Full Text] [Related]
5. Integrating gene and lncRNA expression to infer subpathway activity for tumor analyses.
Zhang C; Xu Y; Yang H; Xu Y; Dong Q; Liu S; Wu T; Zhang Y
Oncotarget; 2017 Dec; 8(67):111433-111443. PubMed ID: 29340065
[TBL] [Abstract][Full Text] [Related]
6. Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.
Feng L; Xu Y; Zhang Y; Sun Z; Han J; Zhang C; Yang H; Shang D; Su F; Shi X; Li S; Li C; Li X
Oncotarget; 2015 Nov; 6(36):39151-64. PubMed ID: 26472186
[TBL] [Abstract][Full Text] [Related]
7. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
[TBL] [Abstract][Full Text] [Related]
8. Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
Ray M; Ruffalo MM; Bar-Joseph Z
Genes Chromosomes Cancer; 2019 Jan; 58(1):34-42. PubMed ID: 30285311
[TBL] [Abstract][Full Text] [Related]
9. Integrating high-throughput microRNA and mRNA expression data to identify risk mRNA signature for pancreatic cancer prognosis.
Wang P; Li W; Zhai B; Jiang X; Jiang H; Zhang C; Sun X
J Cell Biochem; 2020 Jun; 121(5-6):3090-3098. PubMed ID: 31886578
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
11. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
[TBL] [Abstract][Full Text] [Related]
12. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
Liu F; Zhang G; Lv S; Wen X; Liu P
J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
[TBL] [Abstract][Full Text] [Related]
13. Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer.
Han J; Liu S; Jiang Y; Xu C; Zheng B; Jiang M; Yang H; Su F; Li C; Zhang Y
J Cell Mol Med; 2018 Sep; 22(9):4304-4316. PubMed ID: 29971923
[TBL] [Abstract][Full Text] [Related]
14. Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
Bignotti E; Calza S; Tassi RA; Zanotti L; Bandiera E; Sartori E; Odicino FE; Ravaggi A; Todeschini P; Romani C
J Cell Mol Med; 2016 Dec; 20(12):2341-2348. PubMed ID: 27419385
[TBL] [Abstract][Full Text] [Related]
15. ce-Subpathway: Identification of ceRNA-mediated subpathways via joint power of ceRNAs and pathway topologies.
Feng C; Song C; Ning Z; Ai B; Wang Q; Xu Y; Li M; Bai X; Zhao J; Liu Y; Li X; Zhang J; Li C
J Cell Mol Med; 2019 Feb; 23(2):967-984. PubMed ID: 30421585
[TBL] [Abstract][Full Text] [Related]
16. DAAM1-mediated migration and invasion of ovarian cancer cells are suppressed by miR-208a-5p.
Mei J; Huang Y; Hao L; Liu Y; Yan T; Qiu T; Xu R; Xu B; Xiao Z; Jiang X; Hu K; Zhu Y
Pathol Res Pract; 2019 Jul; 215(7):152452. PubMed ID: 31104928
[TBL] [Abstract][Full Text] [Related]
17. Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.
Liang ZQ; He RQ; Luo JY; Huang ZG; Li J; Zhong LY; Chen JH; Huang SN; Shi L; Wei KL; Zeng JH; Zeng JJ; Chen G
Pathol Oncol Res; 2022; 28():1610404. PubMed ID: 35911442
[No Abstract] [Full Text] [Related]
18. Identification of prognostic signature in cancer based on DNA methylation interaction network.
Hu WL; Zhou XH
BMC Med Genomics; 2017 Dec; 10(Suppl 4):63. PubMed ID: 29322932
[TBL] [Abstract][Full Text] [Related]
19. Cancer survival classification using integrated data sets and intermediate information.
Kim S; Park T; Kon M
Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860
[TBL] [Abstract][Full Text] [Related]
20. Identifying miRNA-mediated signaling subpathways by integrating paired miRNA/mRNA expression data with pathway topology.
Vrahatis AG; Dimitrakopoulos GN; Tsakalidis AK; Bezerianos A
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():3997-4000. PubMed ID: 26737170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
